RoSA Lung Cancer Screening Software Market to 2032
Overview
The RoSA Lung Cancer Screening Software Market is expected to reach a 0.48 USD Million by 2032 and is projected to grow at a CAGR of 25.09% from 2025 to 2032.
Revenue, 2024 (USD Million)
0.17
Forecast, 2032 (USD Million)
0.48
CAGR, 2024 - 2032
25.09%
Report Coverage
RoSA
RoSA Lung Cancer Screening Software Market 2018-2032 USD Million
RoSA Lung Cancer Screening Software Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 0.17 USD Million
- Projected Market Size (2032): 0.48 USD Million
- CAGR (2025-2032): 25.09%
Key Findings of RoSA Lung Cancer Screening Software Market
- The RoSA Lung Cancer Screening Software Market was valued at 0.17 USD Million in 2024.
- The RoSA Lung Cancer Screening Software Market is likely to grow at a CAGR of 25.09% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Institutional in Purchase Mode Segment accounted for the largest share of the market with a revenue of 0.13 USD Million
- The fastest growing segment Oncology Centers in End User Segment grew Fastest with a CAGR of 27.76% during the forecast period from 2024 to 2032.
RoSA Lung Cancer Screening Software Market Scope
RoSA Lung Cancer Screening Software Market Segmentation & Scope
Platform
- Integrated
- Standalone
Purchase Mode
- Individual
- Institutional
End User
- Others
- Ambulatory Surgical Centers
- Hospitals
- Oncology Centers
Distribution Channel
- Third Party Distributor
- Direct Tenders
Type
- Traditional Screening
- Computer-Assisted Screening
Application
- Small Cell Lung Cancer (SCLC)
- Non-Small Cell Lung Cancer (NSCLC)
Mode of Delivery
- Web Based Solutions1
- On-Premise Solutions1
- Cloud Based Solutions1
Product
- Audit Log Tracking
- Practice Management
- Screening PACs
- Statistical Audit Reporting
- Pathology and Cancer Staging
- Lung Nodule Computer Aided Detection
- Patient Coordination and Workflow
- Data Collection and Reporting
- Nodule Management Software
- Lung Cancer Screening Patient Management Software
- Lung Cancer Screening Radiology Solution
RoSA Lung Cancer Screening Software Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 0.17 USD Million |
| Market Value in 2032 | 0.48 USD Million |
| CAGR (2025-2032) | 25.09% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Platform,Purchase Mode,End User,Distribution Channel,Type,Application,Mode of Delivery,Product |
Regional Insights:
-
Leading Market (2024-2032): RoSA, leading in terms of revenue 0.17 USD Million in 2024
- Key Country: RoSA, leading in terms of revenue with value of 0.17 USD Million in 2024.
Segments and Scope
-
RoSA Lung Cancer Screening Software Market to 2032, By Platform
- Standalone is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.10 USD Million in the year 2024.
- Integrated is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 23.33 % in forecast period 2025-2032.
-
RoSA Lung Cancer Screening Software Market to 2032, By Purchase Mode
- Institutional is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.13 USD Million in the year 2024.
- Institutional is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 26.26 % in forecast period 2025-2032.
-
RoSA Lung Cancer Screening Software Market to 2032, By End User
- Oncology Centers is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.11 USD Million in the year 2024.
- Oncology Centers is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 27.76 % in forecast period 2025-2032.
-
RoSA Lung Cancer Screening Software Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.11 USD Million in the year 2024.
- Direct Tenders is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 27.18 % in forecast period 2025-2032.
-
RoSA Lung Cancer Screening Software Market to 2032, By Type
- Computer-Assisted Screening is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.12 USD Million in the year 2024.
- Computer-Assisted Screening is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 26.72 % in forecast period 2025-2032.
-
RoSA Lung Cancer Screening Software Market to 2032, By Application
- Non-Small Cell Lung Cancer (NSCLC) is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.12 USD Million in the year 2024.
- Non-Small Cell Lung Cancer (NSCLC) is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 26.79 % in forecast period 2025-2032.
-
RoSA Lung Cancer Screening Software Market to 2032, By Mode of Delivery
- Cloud Based Solutions1 is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.08 USD Million in the year 2024.
- Web Based Solutions1 is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 25.98 % in forecast period 2025-2032.
-
RoSA Lung Cancer Screening Software Market to 2032, By Product
- Lung Cancer Screening Radiology Solution is the largest segment in RoSA Lung Cancer Screening Software Market to 2032 with a revenue of 0.05 USD Million in the year 2024.
- Nodule Management Software is the Fastest growing segment in RoSA Lung Cancer Screening Software Market to 2032 with a Growth rate of 25.41 % in forecast period 2025-2032.
RoSA Lung Cancer Screening Software Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Oncocyte Corporation | |||
| Nuance Communications, Inc. | |||
| Koninklijke Philips N.V. | |||
| Thynk Health | |||
RoSA Lung Cancer Screening Software Market Geographical Sales Distribution, 2018-2032 USD Million
RoSA Lung Cancer Screening Software Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoSA Lung Cancer Screening Software Market is segmented based on Segmentation Platform,Purchase Mode,End User,Distribution Channel,Type,Application,Mode of Delivery,Product.
RoSA Lung Cancer Screening Software Market was valued at USD 0.17(Revenue in USD Million) in 2019.
RoSA Lung Cancer Screening Software Market is projected to grow at a CAGR of 25.09% during the forecast period of 2024 to 2032.
The Institutional segment is expected to dominate the RoSA Lung Cancer Screening Software Market, holding a largest market share of 0.13 USD Million in 2024
RoSA Lung Cancer Screening Software Market Scope
RoSA Lung Cancer Screening Software Market Segmentation & Scope
Platform
- Integrated
- Standalone
Purchase Mode
- Individual
- Institutional
End User
- Others
- Ambulatory Surgical Centers
- Hospitals
- Oncology Centers
Distribution Channel
- Third Party Distributor
- Direct Tenders
Type
- Traditional Screening
- Computer-Assisted Screening
Application
- Small Cell Lung Cancer (SCLC)
- Non-Small Cell Lung Cancer (NSCLC)
Mode of Delivery
- Web Based Solutions1
- On-Premise Solutions1
- Cloud Based Solutions1
Product
- Audit Log Tracking
- Practice Management
- Screening PACs
- Statistical Audit Reporting
- Pathology and Cancer Staging
- Lung Nodule Computer Aided Detection
- Patient Coordination and Workflow
- Data Collection and Reporting
- Nodule Management Software
- Lung Cancer Screening Patient Management Software
- Lung Cancer Screening Radiology Solution
Frequently Asked Questions
The RoSA Lung Cancer Screening Software Market is segmented based on Segmentation Platform,Purchase Mode,End User,Distribution Channel,Type,Application,Mode of Delivery,Product.
RoSA Lung Cancer Screening Software Market was valued at USD 0.17(Revenue in USD Million) in 2019.
RoSA Lung Cancer Screening Software Market is projected to grow at a CAGR of 25.09% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA Lung Cancer Screening Software Market for final year is USD 0.48 (USD Million).
RoSA Lung Cancer Screening Software Market Company Profiling
Frequently Asked Questions
The RoSA Lung Cancer Screening Software Market is segmented based on Segmentation Platform,Purchase Mode,End User,Distribution Channel,Type,Application,Mode of Delivery,Product.
RoSA Lung Cancer Screening Software Market was valued at USD 0.17(Revenue in USD Million) in 2019.
RoSA Lung Cancer Screening Software Market is projected to grow at a CAGR of 25.09% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA Lung Cancer Screening Software Market for final year is USD 0.48 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.